The objective of the Molecular Therapeutics Core is to facilitate the transition from discovery of small molecule therapeutics through validation to their eventual out-licensing or commercialization
for substance use disorders (SUDs) and related disorders. This resource provides CAR researchers unique tools for development of their early-stage discoveries by offering collaborations with chemists interested in conducting translational research.